Fidelity Japan holds a quantitatively derived Silver Morningstar Medalist Rating. The rating reflects that it has scored well on factors Morningstar research associates with future outperformance relative to category peers.
Fidelity Japan Fund FJPNX
- NAV / 1-Day Return 23.63 / −1.66 %
- Total Assets 1.1B
-
Adj. Expense Ratio
0.740%
- Expense Ratio 0.740%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Japan Stock
- Investment Style Large Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 3.49%
- Turnover 39%
USD | NAV as of Jun 10, 2026 | 1-Day Return as of Jun 10, 2026, 4:50 AM GMT+0
Morningstar’s Analysis FJPNX
Will FJPNX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
The People Pillar is our evaluation of the FJPNX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.
Parent Pillar
The Parent Pillar is our rating of FJPNX’s parent organization’s priorities and whether they’re in line with investors’ interests.
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 29.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Sumitomo Mitsui Financial Group Inc | 5.34 | 55M | Financial Services |
Hitachi Ltd | 3.77 | 39M | Industrials |
Toyota Motor Corp | 3.30 | 34M | Consumer Cyclical |
Renesas Electronics Corp | 2.80 | 29M | Technology |
Kioxia Holdings Corp Ordinary Shares | 2.66 | 28M | Technology |
Hoya Corp | 2.52 | 26M | Healthcare |
Mizuho Financial Group Inc | 2.49 | 26M | Financial Services |
Furukawa Electric Co Ltd | 2.33 | 24M | Industrials |
ORIX Corp | 2.22 | 23M | Financial Services |
Chugai Pharmaceutical Co Ltd | 2.16 | 22M | Healthcare |
United States